Hikma and GSK have agreed not to proceed with a deal being explored by the two firms that would have seen Hikma acquire a majority stake in the firm’s pharmaceutical and consumer health business in Egypt and Tunisia.
Hikma and GlaxoSmithKline have decided not to proceed with a deal that would have seen Hikma acquire a majority stake in the firm’s pharmaceutical and consumer health business in Egypt and Tunisia, the companies have announced.
In January, Hikma revealed that it had entered a non-binding term sheet for GSK’s pharmaceutical and consumer businesses in Egypt...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
